Advances in the treatment of atopic dermatitis with special regard to children.
Oranje
A P
AP
Department of Dermatology and Venereology, University Hospital Rotterdam, The Netherlands. oranje@alkg.azr.nl/aoranje@inter.NL.net
Wolkerstorfer
A
A
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D000485:Allergens / Q000009:adverse effects; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000517:prevention & control; D001494:Baths / Q000009:adverse effects; D002648:Child; D003033:Coal Tar / Q000009:adverse effects / Q000627:therapeutic use; D000529:Complementary Therapies; D003876:Dermatitis, Atopic / Q000517:prevention & control / Q000628:therapy*; D004643:Emollients; D004781:Environmental Exposure; D005512:Food Hypersensitivity / Q000150:complications / Q000178:diet therapy; D005544:Forecasting; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy; D007239:Infections / Q000150:complications; D009779:Occlusive Dressings; D012915:Soaps / Q000009:adverse effects; D013315:Stress, Psychological / Q000150:complications
D000305:Adrenal Cortex Hormones; D000485:Allergens; D018927:Anti-Asthmatic Agents; D004643:Emollients; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D012915:Soaps; D003033:Coal Tar